There are 16 Drug Discovery investors in the AngelBacked database, ranked below by portfolio size. The most active include Peter Roshko, Kyle Lefkoff and Jonathan Perl. Each profile lists portfolio companies, sector focus, check size, and contact details.
Chief Strategy & Marketing Officer, AKA
Chief Growth and Corporate Development Officer
Sign up to view contact details, LinkedIn profiles, and export investor data.
AngelBacked lists 16 angel investors and VCs who invest in Drug Discovery startups. The most active by portfolio size include Peter Roshko, Kyle Lefkoff, Jonathan Perl.
Ranked by number of portfolio companies, the most active Drug Discovery investors in the AngelBacked database are Peter Roshko, Kyle Lefkoff, Jonathan Perl. Each profile lists their portfolio, sector focus, and contact details.
Every Drug Discovery investor profile on AngelBacked includes a verified email address alongside their portfolio companies, sector focus, and firm. Paid plans unlock the contact details and CSV export.
Check sizes vary by stage: angel investors backing Drug Discovery startups typically write $25K–$100K, while Drug Discovery-focused VCs range from $500K to $5M+ for early-stage rounds. Filter the database by check size to match your raise.